Evidence map›Paper›PMID 26657743›Full record

ArticleBrain research2016

Nociceptin receptor activation does not alter acquisition, expression, extinction and reinstatement of conditioned cocaine preference in mice.

G C Sartor, S K Powell, H J Wiedner, C Wahlestedt, S P Brothers

Abstract read
In one paragraph

Article in Brain research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.1field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. NOP-Related Mechanisms in Substance Use Disorders.Handbook of experimental pharmacology · 2019
    Article
  3. Article
  4. Article
  5. Genetic Deletion of the Nociceptin/Orphanin FQ Receptor in the Rat Confers Resilience to the Development of Drug Addiction.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2017
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

G C Sartor *Center for Therapeutic Innovation (CTI) and Department of Psychiatry & Behavioral Sciences, University of Miami Miller School of Medicine.
S K Powell *Center for Therapeutic Innovation (CTI) and Department of Psychiatry & Behavioral Sciences, University of Miami Miller School of Medicine.
H J WiednerCenter for Therapeutic Innovation (CTI) and Department of Psychiatry & Behavioral Sciences, University of Miami Miller School of Medicine.
C WahlestedtCenter for Therapeutic Innovation (CTI) and Department of Psychiatry & Behavioral Sciences, University of Miami Miller School of Medicine.
S P BrothersCenter for Therapeutic Innovation (CTI) and Department of Psychiatry & Behavioral Sciences, University of Miami Miller School of Medicine.
University of Miami · US

Funding

Epigenetic Signaling Pathways Contributing to Alcohol DependenceR01AA023781 · NIAAA · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI HEILIG, MARKUS ALEXANDER, WAHLESTEDT, CLAES ROBERT · 2015 to 2019
$2.1M
Small Molecule Identification for the Nociceptin Receptor to Treat Cocaine AbuseR01DA035055 · NIDA · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI WAHLESTEDT, CLAES ROBERT · 2012 to 2016
$1.7M
Discovery and development of nociceptin receptor ligands in alcohol dependenceR01AA017943 · NIAAA · SCRIPPS FLORIDA · PI BANNISTER, THOMAS D · 2009 to 2010
$970k
Neuronal subtype and circuit-specific epigenetic mechanisms in addictionK99DA040744 · NIDA · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI SARTOR, GREGORY CHARLES · 2016 to 2017
$262k
Howard Hughes Medical Institute 52006951NIAAA NIH HHS R01 AA017943NIAAA NIH HHS R01 AA023781NIDA NIH HHS K99 DA040744NIDA NIH HHS R01 DA035055NIDA NIH HHS R01DA035055
6 · The paper itself

Abstract

Growing evidence indicates that targeting nociceptin receptor (NOP) signaling may have therapeutic efficacy in treating alcohol and opioid addiction. However, little is known about the therapeutic value of selective NOP agonists for the treatment of cocaine dependence. Recently, we identified a highly selective, brain-penetrant NOP small molecule agonist (SR-8993), and using this compound, we previously showed that nociceptin receptor activation attenuated consolidation of fear-related memories. Here, we sought to determine whether SR-8993 also affects the rewarding properties of cocaine. Using a conditioned place preference (CPP) procedure, we show that SR-8993 (3 or 10 mg/kg) failed to disrupt acquisition or expression of cocaine CPP (7.5 or 15 mg/kg) in C57BL/6 mice. Additionally, SR-8993 did not affect rate of extinction or reinstatement (yohimbine- and cocaine-induced) of cocaine CPP. These studies indicate that selective activation of NOP may not be sufficient in reducing behavioral responses to cocaine.

Indexed as

AnimalsBehavior, AddictiveCocaineConditioning, PsychologicalExtinction, PsychologicalMaleMiceMice, Inbred C57BLNociceptin ReceptorReceptors, OpioidYohimbineCocaineNociceptin ReceptorOprl1 protein, mouseReceptors, OpioidYohimbineCocaineConditioned place preferenceNociceptin

Identifiers

PMID26657743
PMCPMC4733396
OpenAlexW2196209097

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.